Cargando…
Selective Persistence of HPV Cross-Neutralising Antibodies following Reduced-Dose HPV Vaccine Schedules
The duration of cross-neutralising antibody responses (cross-NAb) following HPV immunisation is unknown. We compared cross-NAb responses in cohort of girls who were either unimmunised or had received immunisation with one, two or three doses of 4vHPV (Gardasil(®), Merck Inc., Kenilworth, NJ, USA) si...
Autores principales: | Toh, Zheng Quan, Kosasih, Jennie, Russell, Fiona M., Reyburn, Rita, Fong, James, Tuivaga, Evelyn, Ratu, Felisita T., Nguyen, Cattram D., Matanitobua, Silivia, Do, Lien Anh Ha, Menheniott, Trevelyan, Frazer, Ian H., Garland, Suzanne M., Mulholland, Edward Kim, Licciardi, Paul V. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6963583/ https://www.ncbi.nlm.nih.gov/pubmed/31795211 http://dx.doi.org/10.3390/vaccines7040200 |
Ejemplares similares
-
Cellular Immune Responses 6 Years Following 1, 2, or 3 Doses of Quadrivalent HPV Vaccine in Fijian Girls and Subsequent Responses to a Dose of Bivalent HPV Vaccine
por: Toh, Zheng Quan, et al.
Publicado: (2018) -
A single dose of quadrivalent HPV vaccine is highly effective against HPV genotypes 16 and 18 detection in young pregnant women eight years following vaccination: an retrospective cohort study in Fiji
por: Reyburn, Rita, et al.
Publicado: (2023) -
Editorial: Immunology of HPV Infection and Vaccination: Progress and Challenges
por: Licciardi, Paul V., et al.
Publicado: (2021) -
Epidemiology of intussusception before and after rotavirus vaccine introduction in Fiji
por: Ratu, Felisita Tupou, et al.
Publicado: (2018) -
Measurement of Human Papillomavirus-Specific Antibodies Using a Pseudovirion-Based ELISA Method
por: Toh, Zheng Quan, et al.
Publicado: (2020)